Intellia Therapeutics's chart data is dated 2026-10-08. There is no active technical signal. There are 0 published signal records.
Intellia Therapeutics last closed at $12.60 (+7.60%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is -4.2×. Its overall grade ranks 428 of 738 stocks in Healthcare.
About this company
Intellia Therapeutics last closed at $12.60 (+7.60%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 428/738
Valuation grade B
Related stocks
- Regeneron PharmaceuticalsCustomer
유전자편집 치료제 공동개발 파트너
- NovartisCustomer
INTELLIA의 연구·개발 협력 및 잠재 상업화 파트너
- AstraZenecaCustomer
유전자편집 치료제 관련 협력 파트너
About Intellia Therapeutics
- What technical signals does Intellia Therapeutics (NTLA) have?
- Intellia Therapeutics current technical signals: no active technical signal.
- Is Intellia Therapeutics a cup-and-handle pattern?
- No. Intellia Therapeutics has no valid Cup signal right now.
- What published figures are available for Intellia Therapeutics?
- Market cap: $1.46B. Trailing 12 months PER: -4.2×. Latest quarter PBR: 2.31×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Intellia Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.